Opioid use disorder is a serious public health burden, especially throughout rural America. Although efforts have been made to increase the availability of buprenorphine (an office-based medication-assisted treatment), more than 60% of rural counties in the U.S. lack a physician with a Drug Enforcement Administration waiver to prescribe it.
This study surveyed all rural physicians with a Drug Enforcement Administration waiver in 2016 to prescribe buprenorphine for opioid use disorder in the U.S. and asked about physician’s demographics, prescribing practices, and barriers to prescribing buprenorphine for treatment of opioid use disorder.
Authors:Andrilla CHA, Coulthard C, Patterson DG
Journal/Publisher:American Journal of Preventive Medicine
Edition:Jun 2018. Volume 54, Issue 6, Supplement 3, Pages S208–S214
Link to ArticleAccess the article here: American Journal of Preventive Medicine
Citation:Andrilla CHA, Coulthard C, Patterson DG. Prescribing Practices Of Rural Physicians Waivered To Prescribe Buprenorphine. American Journal of Preventive Medicine. Jun 2018 Volume 54, Issue 6, Supplement 3, Pages S208–S214
Related Studies:Who Treats Opioid Addiction in Rural America? Quantifying the Availability of Buprenorphine Services in Rural Areas